Kwong Yok Tsang[Author] - Search Results

Year	Number of Results
2002	1
2003	5
2004	4
2005	5
2006	3
2008	3
2009	2
2010	3
2011	3
2012	1
2013	4
2014	7
2015	2
2016	2
2022	1
2023	1
2024	0

1

Schlom J, Hodge JW, Palena C, Tsang KY, Jochems C, Greiner JW, Farsaci B, Madan RA, Heery CR, Gulley JL. Schlom J, et al. Among authors: tsang ky. Adv Cancer Res. 2014;121:67-124. doi: 10.1016/B978-0-12-800249-0.00002-0. Adv Cancer Res. 2014. PMID: 24889529 Free PMC article. Review.

2

Development and Characterization of an Anti-Cancer Monoclonal Antibody for Treatment of Human Carcinomas.

Tsang KY, Fantini M, Mavroukakis SA, Zaki A, Annunziata CM, Arlen PM. Tsang KY, et al. Cancers (Basel). 2022 Jun 21;14(13):3037. doi: 10.3390/cancers14133037. Cancers (Basel). 2022. PMID: 35804808 Free PMC article. Review.

3

Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy.

Fantini M, Arlen PM, Tsang KY. Fantini M, et al. Among authors: tsang ky. Front Immunol. 2023 Nov 24;14:1275904. doi: 10.3389/fimmu.2023.1275904. eCollection 2023. Front Immunol. 2023. PMID: 38077389 Free PMC article. Review.

4

Costimulatory molecules as adjuvants for immunotherapy.

Hodge JW, Greiner JW, Tsang KY, Sabzevari H, Kudo-Saito C, Grosenbach DW, Gulley JL, Arlen PM, Marshall JL, Panicali D, Schlom J. Hodge JW, et al. Among authors: tsang ky. Front Biosci. 2006 Jan 1;11:788-803. doi: 10.2741/1837. Front Biosci. 2006. PMID: 16146771 Review.

5

TRICOM vector based cancer vaccines.

Garnett CT, Greiner JW, Tsang KY, Kudo-Saito C, Grosenbach DW, Chakraborty M, Gulley JL, Arlen PM, Schlom J, Hodge JW. Garnett CT, et al. Among authors: tsang ky. Curr Pharm Des. 2006;12(3):351-61. doi: 10.2174/138161206775201929. Curr Pharm Des. 2006. PMID: 16454749 Review.

6

Immunologic monitoring of cellular immune responses in cancer vaccine therapy.

Whiteside TL, Gulley JL, Clay TM, Tsang KY. Whiteside TL, et al. Among authors: tsang ky. J Biomed Biotechnol. 2011;2011:370374. doi: 10.1155/2011/370374. Epub 2011 Jun 7. J Biomed Biotechnol. 2011. PMID: 21687551 Free PMC article. No abstract available.

7

Strategies for the development of PSA-based vaccines for the treatment of advanced prostate cancer.

Arlen PM, Gulley JL, Tsang KY, Schlom J. Arlen PM, et al. Among authors: tsang ky. Expert Rev Vaccines. 2003 Aug;2(4):483-93. doi: 10.1586/14760584.2.4.483. Expert Rev Vaccines. 2003. PMID: 14711334 Review.

8

General keynote: vaccine strategies for the therapy of ovarian cancer.

Hodge JW, Tsang KY, Poole DJ, Schlom J. Hodge JW, et al. Among authors: tsang ky. Gynecol Oncol. 2003 Jan;88(1 Pt 2):S97-104; discussion S110-3. doi: 10.1006/gyno.2002.6694. Gynecol Oncol. 2003. PMID: 12586096 Review. No abstract available.

9

Identification and characterization of agonist epitopes of the MUC1-C oncoprotein.

Jochems C, Tucker JA, Vergati M, Boyerinas B, Gulley JL, Schlom J, Tsang KY. Jochems C, et al. Among authors: tsang ky. Cancer Immunol Immunother. 2014 Feb;63(2):161-74. doi: 10.1007/s00262-013-1494-7. Epub 2013 Nov 15. Cancer Immunol Immunother. 2014. PMID: 24233342 Free PMC article.

10

WEE1 inhibition alleviates resistance to immune attack of tumor cells undergoing epithelial-mesenchymal transition.

Hamilton DH, Huang B, Fernando RI, Tsang KY, Palena C. Hamilton DH, et al. Among authors: tsang ky. Cancer Res. 2014 May 1;74(9):2510-9. doi: 10.1158/0008-5472.CAN-13-1894. Epub 2014 Mar 13. Cancer Res. 2014. PMID: 24626094 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

43 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year